Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12076084 | PMC |
| http://dx.doi.org/10.1007/s00403-025-03948-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Comparable Efficacy Between Tranexamic Acid Intradermal Injection and Pulsed Dye Laser for Treatment of Post-Acne Erythema: A Split-Face Therapy.
Clin Cosmet Investig Dermatol
August 2025
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia.
Post-acne erythema (PAE) is persistent erythema after acne vulgaris (AV) inflammatory lesions have resolved. Pulsed dye laser (PDL) is the gold standard for vascular lesions and is effective for PAE. Tranexamic acid (TA) can reduce vascular endothelial growth, angiogenesis, and inflammation by inhibiting plasminogen activity, and can be used in PAE treatment.
View Article and Find Full Text PDFHealth-related quality of life and correlation with clinical severity in patients with acne: a cross-sectional study at a single centre in China.
BMJ Open
September 2025
Department of Social Medicine and Health Management, School of Public Health,Cheeloo College of Medicine, Shandong University, Jinan, China
Objectives: The presence of acne can significantly impact patients' health-related quality of life (HRQoL); however, the correlation between patient-reported HRQoL impairment and clinician-evaluated severity has been unclear. The objective of the study was to evaluate HRQoL in patients with different acne severity using generic, dermatology-specific and acne-specific instruments and investigate the correlation between clinical severity and HRQoL.
Design: Data for the cross-sectional survey were extracted from March 2017 to December 2018.
Trichoscopic Features of Scalp Psoriasis: Their Association With Disease Severity and Quality of Life in a Hispanic Population.
Int J Dermatol
September 2025
Department of Dermatology, Universidad Autónoma de Nuevo Leon, University Hospital "Dr. José Eleuterio González", Monterrey, Nuevo León, México.
Background: Scalp psoriasis is a common condition that impairs quality of life (QoL). Trichoscopy is a valuable tool for diagnosis, but its correlation with disease severity or patient-reported outcomes, especially in Hispanic populations, remains unclear due to limited data. This study aimed to characterize the trichoscopic findings of scalp psoriasis in a Hispanic cohort and to evaluate their association with clinical severity and QoL measures.
View Article and Find Full Text PDFSafety and Efficacy Profile of Anti-IL17 Treatments in Hidradenitis Suppurativa: Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Actas Dermosifiliogr
August 2025
Servicio de Dermatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.
Background And Objective: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that is difficult to manage, requiring the use of biologic drugs such as anti-TNFα and anti-interleukin 17 (anti-IL17). The aim of our review is to evaluate the safety and efficacy profile of anti-IL17 drugs in patients with HS.
Materials And Methods: We conducted a systematic review with subsequent meta-analysis following the population, intervention, comparison, outcome and type of study (PICOS) method.
A systematic review of novel Phosphodiesterase-4 inhibitors in the treatment of psoriasis.
Inflamm Res
August 2025
Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Khaghani St, Tehran, 1916893813, Iran.
Background: Psoriasis is a chronic immune-mediated skin disease that significantly impacts patients' quality of life due to its physical, psychological, and systemic burden. Phosphodiesterase-4 (PDE-4) plays a pivotal role in the inflammatory cascade of the disease through the modulation of intracellular cyclic adenosine monophosphate (cAMP) levels. This systematic review evaluates current evidence on the clinical efficacy and safety of novel PDE-4 inhibitors in the treatment of psoriasis.
View Article and Find Full Text PDF